Global Canine and Feline Blood Typing Tests Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

According to our (Global Info Research) latest study, the global Canine and Feline Blood Typing Tests market size was valued at US$ 25.68 million in 2025 and is forecast to a readjusted size of US$ 43.24 million by 2032 with a CAGR of 7.4% during review period.
Canine and Feline Blood Typing Tests are disposable veterinary in-vitro diagnostic products designed for rapid identification of clinically relevant red blood cell antigens in dogs and cats. Commercial products are primarily supplied as agglutination cards or immunochromatographic test formats and are typically used with anticoagulated whole blood or prepared red blood cell samples. In canine testing, commercial products are centered on DEA 1 typing, with additional assays available for DEA 4, DEA 5 and Dal antigens. Feline products primarily determine A, B and AB blood types within the feline AB blood group system. These tests are designed for point-of-care use and generally provide visually interpretable results within minutes without requiring large laboratory analyzers. Major use scenarios include blood typing before clinical transfusion, screening and classification of canine and feline blood donors, management of veterinary blood bank inventories and feline breeding programs where blood type compatibility is clinically relevant.
Key Findings
Global sales volume was approximately 240 K kits in 2025 and is estimated at approximately 258 K kits in 2026
Global weighted average selling price increased from approximately US$104 per kit in 2025 to approximately US$106 per kit in 2026
Commercial product portfolios are concentrated around canine DEA typing and feline A, B and AB blood typing
Demand is concentrated in clinical transfusion and blood donor management, while feline breeding represents a distinct additional application
The validated competitive pool includes 17 core suppliers across North America, Europe and Asia
Market Trends
The Canine and Feline Blood Typing Tests market is moving toward faster point-of-care workflows, simpler sample handling and more standardized visual interpretation. Agglutination cards remain established in veterinary transfusion medicine, while immunochromatographic formats are gaining importance because they can simplify operating procedures and support rapid testing in emergency and general veterinary settings. Product development is also expanding beyond basic canine DEA 1 identification toward additional canine antigens such as DEA 4, DEA 5 and Dal, although these extended typing products remain more specialized. In feline testing, combined A, B and AB identification continues to represent the mainstream commercial configuration because one test can support transfusion decisions, donor management and breeding-related screening. Multi-test packaging is increasingly relevant to blood banks and high-volume veterinary hospitals, while smaller packages remain suited to general clinics with relatively low testing frequency.
Market Dynamics
Drivers
Growth is supported by the continued expansion of companion animal emergency care, oncology, complex surgery and treatment of severe anemia, all of which increase the need for safer veterinary transfusion practices. Expansion of canine and feline blood donor programs also creates recurring demand for donor typing and blood inventory management. Greater awareness of transfusion compatibility among veterinary professionals is encouraging wider use of point-of-care blood typing before transfusion, while feline breeding management provides an additional demand source because blood group incompatibility can be clinically significant in breeding programs.
Restraints
Blood typing remains a relatively low-frequency diagnostic procedure compared with routine infectious disease rapid testing, limiting test consumption in smaller veterinary clinics. Demand is also uneven across regions because access to veterinary blood banking, emergency care and advanced transfusion services varies substantially. Differences in kit size, test technology and regional pricing complicate standardized purchasing and inventory planning, while specialized canine blood group assays outside DEA 1 address comparatively narrow clinical populations and therefore support smaller production runs.
Opportunities
The strongest opportunities are associated with wider adoption of structured veterinary blood donor networks, expansion of emergency and referral hospitals and increasing penetration of point-of-care diagnostics in emerging companion animal healthcare markets. Asia is becoming more important both as a manufacturing base and as an incremental demand market. Suppliers also have opportunities to develop simplified workflows, smaller clinic-oriented packs, higher-throughput blood bank formats and broader canine antigen panels. Feline blood typing has additional room for penetration in professional breeding programs where blood type screening remains less standardized than in specialist transfusion settings.
Challenges
The industry faces persistent challenges related to assay standardization, lot-to-lot consistency and reliable interpretation of weak or atypical reactions. Canine blood group complexity is greater than the commonly tested DEA 1 system, making expanded typing technically and commercially more difficult. Manufacturers must also balance relatively limited annual demand for specialized blood group products against the need for stringent quality control, stable antibody supply and regional veterinary diagnostic compliance. Differences in clinical practice and transfusion protocols across countries can further slow the formation of a globally standardized testing workflow.
Industry Chain Analysis
The upstream segment of Canine and Feline Blood Typing Tests mainly consists of monoclonal and polyclonal blood group antibodies, membrane materials, sample and absorbent pads, conjugation materials, card substrates, plastic housings, buffer reagents and diagnostic packaging components. Antibody specificity and stability are particularly important because they directly determine blood group recognition accuracy, while membrane consistency and reagent formulation influence migration characteristics, reaction clarity and result interpretation. Midstream manufacturers integrate assay development, antibody preparation or sourcing, reagent formulation, card or strip assembly, quality control, packaging and veterinary diagnostic compliance. Established specialists may control key antibody or assay-development capabilities internally, while some suppliers use external raw-material partners or OEM manufacturing. Downstream demand comes mainly from veterinary hospitals, emergency and referral centers, animal blood banks, donor programs and professional feline breeding operations. Value creation therefore concentrates on assay reliability, ease of use, rapid result generation, regulatory compliance and distribution access rather than on the physical card itself.
Segment Insights
By product type, the market is divided into Canine Blood Typing Tests and Feline Blood Typing Tests. Canine products are primarily associated with transfusion safety and donor screening, with DEA 1 representing the most broadly commercialized antigen target. DEA 4, DEA 5 and Dal testing extends the market into more specialized transfusion cases and donor characterization. Feline products focus on the AB blood group system and typically identify A, B and AB phenotypes within a single testing workflow, giving the segment broader application across transfusion, donor management and breeding.
By detection technology, Agglutination Blood Typing Cards and Immunochromatographic Blood Typing Tests represent the two mainstream commercial formats. Agglutination products benefit from established clinical familiarity, while immunochromatographic products emphasize simple workflows and clear visual readout. From the application perspective, Clinical Transfusion and Blood Donor Screening and Blood Banking account for the core professional demand, while Feline Breeding Management forms a smaller but clearly differentiated application segment.
Downstream Market Opportunities
Veterinary emergency and referral medicine represents the most important professional demand environment because severe anemia, trauma, surgery and other transfusion-dependent cases require rapid blood compatibility decisions. Veterinary blood banks and organized donor programs create more stable recurring demand because animals must be typed when entering donor programs and blood inventories must be managed by compatible blood group. Feline breeding provides a separate opportunity, particularly among professional breeders seeking to manage blood group incompatibility and reduce neonatal isoerythrolysis risk. Expansion of advanced veterinary care in emerging markets is expected to broaden the addressable customer base for both clinic-oriented small packs and higher-volume blood bank formats.
Regional Insights
North America and Western Europe represent the most mature markets for veterinary transfusion medicine, supported by established emergency hospitals, referral centers, blood banks and professional veterinary networks. These regions also host several long-established specialist suppliers and generally show higher adoption of pre-transfusion testing and structured donor management. Europe has a particularly strong manufacturing presence in France, Italy and the United Kingdom.
Asia-Pacific is becoming increasingly important on the supply side, with established and emerging manufacturers in China, South Korea and Taiwan. China has developed a comparatively broad manufacturing base covering agglutination and immunochromatographic products and is also becoming a more important demand market as advanced companion animal hospitals expand. Japan, India and Southeast Asia currently show a stronger dependence on imported products and local distribution networks than on domestic blood typing test manufacturing, creating opportunities for international suppliers and regional OEM manufacturers.
Competitive Landscape Analysis
The competitive landscape remains specialized and relatively fragmented, with 17 validated core suppliers identified across the United States, Europe, South Korea, Taiwan and China. Established specialists such as DMS Laboratories through RapidVet, Alvedia and Agrolabo have accumulated long-term experience in veterinary transfusion diagnostics and maintain broad international distribution exposure. European suppliers generally compete through clinical specialization, established blood typing portfolios and veterinary channel penetration, while Asian manufacturers increasingly compete through flexible product development, OEM capability, broader rapid-test manufacturing infrastructure and competitive production economics. China has become the largest concentration of newly identified manufacturing participants in the current supplier pool, including companies with established veterinary POCT production platforms as well as newer entrants introducing feline and canine blood typing products. Competition therefore increasingly combines clinical brand recognition and proprietary assay capability with manufacturing scale, channel coverage, packaging flexibility and regional pricing.
Report Scope
This report is a detailed and comprehensive analysis for global Canine and Feline Blood Typing Tests market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Canine and Feline Blood Typing Tests market size and forecasts, in consumption value ($ Million), sales quantity (Kits), and average selling prices (US$/Kit), 2021-2032
Global Canine and Feline Blood Typing Tests market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kits), and average selling prices (US$/Kit), 2021-2032
Global Canine and Feline Blood Typing Tests market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kits), and average selling prices (US$/Kit), 2021-2032
Global Canine and Feline Blood Typing Tests market shares of main players, shipments in revenue ($ Million), sales quantity (Kits), and ASP (US$/Kit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Canine and Feline Blood Typing Tests
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Canine and Feline Blood Typing Tests market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include DMS Laboratories, Inc., Alvedia, Agrolabo S.p.A., Rapid Labs Limited, Biopanda Reagents Ltd, VetAll Laboratories, Korea Animal Blood Bank, Bioguard Corporation, Ring Biotechnology Co., Ltd., Xiamen Kangcui Biotechnology Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Canine and Feline Blood Typing Tests market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market Segmentation
Market segment by Type
Canine Blood Typing Tests
Feline Blood Typing Tests
Market segment by Blood Group Target
Canine DEA 1 Blood Typing Tests
Canine DEA 4 Blood Typing Tests
Canine DEA 5 Blood Typing Tests
Canine Dal Blood Typing Tests
Feline AB System Blood Typing Tests
Other
Market segment by Application
Clinical Transfusion
Blood Donor Screening and Blood Banking
Feline Breeding Management
Other
Major players covered
DMS Laboratories, Inc.
Alvedia
Agrolabo S.p.A.
Rapid Labs Limited
Biopanda Reagents Ltd
VetAll Laboratories
Korea Animal Blood Bank
Bioguard Corporation
Ring Biotechnology Co., Ltd.
Xiamen Kangcui Biotechnology Co., Ltd.
HANGZHOU ALLTEST BIOTECH CO.,LTD
Healvet Medtech GZ Ltd.
Guangzhou Herun Biopharm Co., Ltd.
Hangzhou ITGen Technology Co., Ltd.
Zhejiang Anji Safheal Biotechnology Co., Ltd.
Guangzhou Pluslife Technology Co., Ltd.
CHONGQING SAFVET BIOTECH CO.,LTD
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Canine and Feline Blood Typing Tests product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Canine and Feline Blood Typing Tests, with price, sales quantity, revenue, and global market share of Canine and Feline Blood Typing Tests from 2021 to 2026.
Chapter 3, the Canine and Feline Blood Typing Tests competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Canine and Feline Blood Typing Tests breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Canine and Feline Blood Typing Tests market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Canine and Feline Blood Typing Tests.
Chapter 14 and 15, to describe Canine and Feline Blood Typing Tests sales channel, distributors, customers, research findings and conclusion.